Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.

Citation data:

Cell stem cell, ISSN: 1875-9777, Vol: 19, Issue: 2, Page: 154-157

Publication Year:
2016
Captures 123
Readers 123
Mentions 88
News Mentions 59
Blog Mentions 27
Comments 1
Economics Blog Mentions 1
Social Media 391
Shares, Likes & Comments 202
Tweets 189
Citations 88
Citation Indexes 88
Ratings
Reddit 1
PMID:
27374789
DOI:
10.1016/j.stem.2016.06.007
Author(s):
Turner, Leigh; Knoepfler, Paul
Publisher(s):
Elsevier BV
Tags:
Biochemistry, Genetics and Molecular Biology
Most Recent Tweet View All Tweets
Most Recent Blog Mention
Most Recent Economics Blog Mention
Most Recent News Mention
article description
Direct-to-consumer marketing of unapproved stem cell interventions is a well-known phenomenon in countries with lax medical regulations. However, an examination of Internet-based marketing claims revealed widespread promotion of such interventions by businesses based in the United States. Such commercial activity suggests that regulatory agencies must better oversee this marketplace.